Levi J. Rupp
- Oncology top 2%
- Immunology top 2%
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Genetics top 5%
- Co-authors
- Kole T. RoybalWendell A. LimKrista A. McNallyLeonardo MorsutJason S. ParkAlexander MarsonKathrin SchumannRachel E. Gate
- Topics
- CAR-T cell therapy research (8 papers)Immune Cell Function and Interaction (5 papers)T-cell and B-cell Immunology (5 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United States
In The Last Decade
Levi J. Rupp
12 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.5k
- Immunology 1.1k
- Molecular Biology 970
- Biomedical Engineering 635
- Genetics 501
Countries citing papers authored by Levi J. Rupp
This map shows the geographic impact of Levi J. Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi J. Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi J. Rupp more than expected).
Fields of papers citing papers by Levi J. Rupp
This network shows the impact of papers produced by Levi J. Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi J. Rupp. The network helps show where Levi J. Rupp may publish in the future.
Co-authorship network of co-authors of Levi J. Rupp
This figure shows the co-authorship network connecting the top 25 collaborators of Levi J. Rupp. A scholar is included among the top collaborators of Levi J. Rupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levi J. Rupp. Levi J. Rupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cellsbreakdown → | 579 |
| 2 | 2 | |
| 3 | Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptorsbreakdown → | 524 |
| 4 | Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuitsbreakdown → | 727 |
| 5 | 13 | |
| 6 | 29 | |
| 7 | 3 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 3 | |
| 11 | The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturationbreakdown → | 573 |
| 12 | 86 |
About Levi J. Rupp
Levi J. Rupp is a scholar working on Immunology, Oncology and Molecular Biology, having authored 12 papers that have together received 2.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (1.1k citations) and Genetics (501 citations). Levi J. Rupp has collaborated with scholars based in United States. Frequent co-authors include Kole T. Roybal, Wendell A. Lim, Krista A. McNally, Leonardo Morsut, Jason S. Park, Alexander Marson, Kathrin Schumann, Rachel E. Gate, Chun Ye and Joseph C. Sun. Their work appears in journals such as Cell, Journal of Clinical Oncology and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.